.
MergerLinks Header Logo

New Deal


Announced

VTB Capital to acquire 11.2% stake in Binnopharm Group from AFK Sistema for $96m.

Financials

Edit Data
Transaction Value£68m
Consideration TypeCash
Capital Owned-
Capital Bid For11%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Public

Pharmaceuticals

Minority

Domestic

Friendly

Russian Federation

drugs

Pending

Single Bidder

Acquisition

Synopsis

Edit

VTB Capital, an investment bank, agreed to acquire 11.2% stake in Binnopharm Group, a pharmaceutical holding company, from AFK Sistema, a conglomerate company, for $96m. "Binnopharm Group, in particular, and the pharmaceutical sector are investment attractive assets," VTB Capital representative.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US